Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
Sponsor: Guangdong Provincial People's Hospital
Summary
Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the incidence of adverse events and evaluate the safety of the protocol.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-05-25
Completion Date
2028-12-31
Last Updated
2025-05-18
Healthy Volunteers
No
Conditions
Interventions
Indocyanine green (ICG)
Indocyanine green (ICG; National Drug Approval No. H20213567, Ruida Pharmaceuticals) is administered intravenously 24 hours preoperatively at a dose of 2 mg/kg. The drug is dissolved in 250 mL of normal saline using a light-protected infusion set and infused at a constant rate over 60 minutes. Alternatively, a 0.5 mg/kg dose may be administered via IV infusion 1-3 hours before surgery.
Locations (1)
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China